Ocugen, Inc. (OCGN)
0.8076
-0.07
(-7.55%)
USD |
NASDAQ |
Nov 13, 11:01
Ocugen Net Income (Annual) : -67.85M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -67.85M |
| December 31, 2024 | -54.05M |
| December 31, 2023 | -63.08M |
| December 31, 2022 | -86.80M |
| December 31, 2021 | -58.36M |
| December 31, 2020 | -21.82M |
| December 31, 2019 | -20.24M |
| Date | Value |
|---|---|
| December 31, 2018 | -18.22M |
| December 31, 2017 | -26.41M |
| December 31, 2016 | -16.21M |
| December 31, 2015 | -32.02M |
| December 31, 2014 | -10.51M |
| December 31, 2013 | -56.00M |
| December 31, 2012 | 20.76M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Anika Therapeutics, Inc. | -9.979M |
| Nektar Therapeutics | -164.08M |
| Heron Therapeutics, Inc. | -20.20M |
| TG Therapeutics, Inc. | 447.18M |
| Tonix Pharmaceuticals Holding Corp. | -124.02M |